SLX-4090 is an orally active enterocytic-specific microsomal triglyceride transfer protein ( MTP ) inhibitor with an IC 50 of 8.0 nM. SLX-4090 can be used for the research of dyslipidemia.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Obesity | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Microsomal Triglyceride Transfer Protein (MTP)
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。